VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult patients living with gMG – anti-AChR-Ab ...
FDA Approves Label Expansion for generalized myasthenia gravis FDA expands approval of VYVGART and VYVGART Hytrulo to all ...
Decreased AChR-Ab titers correlated with improved myasthenia gravis symptoms, especially in ADL scores, within the first 3 months of treatment. The study found no baseline correlation between AChR-Ab ...
Treatment with efgartigimod IV was associated with a statistically significant and clinically meaningful improvement in MG-ADL total score compared with placebo. Topline results were announced from a ...
Ocular MG is a milder form of generalized MG, with lower AChR titers and less aggressive treatment needs. AChR titers above 100 nmol/L at diagnosis predict progression from ocular to generalized MG.
Decisions about thymectomy in myasthenia gravis (MG) depend on several variables. Two important categories are whether the patient's thymus gland has thymoma or not and what type of autoantibodies, if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results